Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children

Background: Postoperative bloodstream infection (BSI) is the most important determinant of recipient morbidity and mortality after liver transplantation (LT). Children who underwent LT are at the highest risk of developing BSI because of the significant surgical intervention, use of multiple devices, and administration of immunosuppressive agents. However, information regarding the risk factors for BSI in children after LT is limited. Methods: We retrospectively reviewed 210 children who underwent living-donor LT at the largest pediatric LT center in Japan. Patients’ characteristics, blood culture results and clinical outcomes were extracted from electronic medical records. Univariate and multivariate analyses were performed to identify the risk factors for BSI. Results: Among the 210 LT recipients, 53 (25%) recipients experienced 86 episodes of BSI during the observational period. The source of the BSI was identified only in 38%: catheter-related BSI (27%) peritonitis (7%), urinary tract infection (2%), pneumonia (1%) and infectious endocarditis (1%). A multivariate analysis demonstrated that body weight (P = 0.03), volume of blood loss during LT (P < 0.001) and cytomegalovirus (CMV) antigenemia positivity (P = 0.04) were independently associated with the development of BSI. The risk factors for BSI differed when we analyzed the subjects according to age (⩽24 months and >24 months), blood loss and pediatric end-stage liver disease/model for end-stage liver disease versus positive CMV antigenemia. Conclusions: The volume of blood loss, postoperative CMV antigenemia positivity and body weight were associated with the development of BSI after LT in pediatric living-donor recipients. To identify the age-specific predictors of BSI in children who underwent LT, age-specific analyses are crucial.

[1]  A. Kalil,et al.  A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  G. Stragliotto,et al.  Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation. , 2013, Immunobiology.

[3]  A. Webster,et al.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. , 2013, The Cochrane database of systematic reviews.

[4]  S. Yagi,et al.  Pre- and perioperative factors affecting infection after living donor liver transplantation. , 2012, Nutrition.

[5]  M. Mcphail,et al.  Bloodstream Infection After Elective Liver Transplantation Is Associated With Increased Mortality in Patients With Cirrhosis , 2012 .

[6]  S. Oh,et al.  Early bloodstream infection after pediatric living donor living transplantation. , 2012, Transplantation proceedings.

[7]  A. Saitoh,et al.  A Universal Preemptive Therapy for Cytomegalovirus Infections in Children After Live-Donor Liver Transplantation , 2011, Transplantation.

[8]  M. Mizumoto,et al.  Posttransplant bacteremia in adult living donor liver transplant recipients , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  S. Park,et al.  Infections after Living Donor Liver Transplantation in Children , 2010, Journal of Korean medical science.

[10]  R. Moreau,et al.  Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[11]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Kenward,et al.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls , 2009, BMJ : British Medical Journal.

[13]  S. Wie,et al.  Epidemiology and Risk Factors for Bacteremia in 144 Consecutive Living-Donor Liver Transplant Recipients , 2009, Yonsei medical journal.

[14]  Michael D. Green,et al.  Immunizations and infectious diseases in pediatric liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  J. Belghiti,et al.  Risk factors for Enterobacteriaceae bacteremia after liver transplantation , 2008, Transplant international : official journal of the European Society for Organ Transplantation.

[16]  M. Makuuchi,et al.  Bloodstream infection after living donor liver transplantation , 2008, Scandinavian journal of infectious diseases.

[17]  Yoshinobu Sato,et al.  Risk factors and prevention of biliary anastomotic complications in adult living donor liver transplantation. , 2007, World journal of gastroenterology.

[18]  Charles E. McCulloch,et al.  Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .

[19]  Shu-sen Zheng,et al.  Cytomegalovirus and chronic allograft rejection in liver transplantation. , 2004, World journal of gastroenterology.

[20]  J. Minei,et al.  Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. , 2002, The Journal of trauma.

[21]  A. Lindblad,et al.  Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation1 , 2002, Transplantation.

[22]  M. Boeckh,et al.  High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. , 2002, The Journal of infectious diseases.

[23]  Y. Matsui,et al.  Perioperative blood transfusion in hepatocellular carcinomas , 2001, Cancer.

[24]  Nina Singh,et al.  Predicting bacteremia and bacteremic mortality in liver transplant recipients , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[25]  F. Sonnenberg,et al.  Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair , 1999, Transfusion.

[26]  G. Hunninghake,et al.  Cytomegalovirus inhibits CD14 expression on human alveolar macrophages. , 1996, The Journal of infectious diseases.

[27]  R. Wiesner,et al.  Relevance and risk factors of enterococcal bacteremia following liver transplantation. , 1996, Transplantation.

[28]  T. The,et al.  Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. , 1996, Clinical transplantation.

[29]  J. Emond,et al.  Patterns of infection after pediatric liver transplantation. , 1992, American journal of diseases of children.

[30]  D. Triulzi,et al.  A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery , 1992, Transfusion.

[31]  E. J. Erickson,et al.  Cytomegalovirus infection promotes bacterial translocation in thermally injured mice. , 1990, The Journal of burn care & rehabilitation.

[32]  T. Starzl,et al.  Infections after Liver Transplantation: AN ANALYSIS OF 101 CONSECUTIVE CASES , 1988, Medicine.

[33]  J. Gitlin,et al.  Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. , 1984, Blood.

[34]  Y. Ming,et al.  The risk factors for mortality in deceased donor liver transplant recipients with bloodstream infections. , 2013, Transplantation proceedings.

[35]  G. Hunninghake,et al.  Cytomegalovirus Inhibits CD 14 Expression on Human Alveolar Macrophages , 2010 .

[36]  J. Morton,et al.  Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery. , 2002, The Annals of thoracic surgery.

[37]  Shumei S. Guo,et al.  CDC GROWTH CHARTS FOR THE UNITED STATES: METHODS AND DEVELOPMENT 2000 , 2002 .

[38]  M. Torbenson,et al.  Causes of death in autopsied liver transplantation patients. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.